UK small-cap RNS · 27 Oct 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies

07:00

Pennon Group PNN £1,747m
Results Of Rights Issue Results
Pennon Group plc (the “Company”) announces that the 7 for 15 Rights Issue of 220,257,997 New Ordinary Shares at 250 pence per New Ordinary Share announced on 7 October 2026 has closed for acceptances.

Dilutive fundraise +1.7% on the day
07:00

Revolution Beauty Group REVB £39m
Half-year Results Results
Not a new upgrade: the Board says trading is at the top end of market expectations that were already raised on 17 September 2026. This confirms the turnaround is delivering profit.

Turnaround plan with targets in lineoutlook positivefirst since Oct 2023 −3.3% on the day

Moved: new: Margin and cost turnaround – Profitable first half; H2 trading at top end
07:00

Ultimate Products ULTP £40m
Audited Results for the Year Ended 31 July 2026 Results
Final results match consensus (revenue £144.9m, EBITDA £10.0m) and net debt fell, but adjusted EBITDA is down 20%, the dividend is cut to 2.7p and UK branded sales fell 7%.

Turnaround plan with targets in lineoutlook mixed +9.3% on the day
Results reading Revenue, adjusted EBITDA of £10.0m, gross margin and net debt were all in the August trading update, so the new information is below that line. What changed · 11 →
Moved: Commercial function overhaul: Restructuring costed; H2 revenue flat → Restructure done; UK sales still falling
07:00

Shearwater Group SWG £17m
FY26 Results Results
Confirms the 27 July update: revenue £42.3m and adjusted EBITDA £2.6m (£2.5m flagged), a second year of growth, and statutory loss cut to £0.3m. Largely pre-announced, so little surprise.

Not yet sorted £42.3m · 250% of mcapin lineoutlook positivefirst in 7 months −5.7% on the day
Results reading The headline numbers were already known from the July trading update and land marginally above it (revenue £42.3m against c.£42m, adjusted EBITDA £2.6m against £2.5m). What changed · 8 →
Moved: £3.0m adjusted EBITDA in FY26 for full LTIP vesting: pending → missed – FY26 adjusted EBITDA came in at £2.6m, below the £3.0m needed for full LTIP vesting. · Brookcourt £25m telco contract: FY26 benefit shown in upgraded trading update → FY26 revenue recognised; results confirm · Software division return to growth: H1 revenue down 12%; renewals and new clients → FY26 revenue down 17%; growth targeted FY27
07:00

Inspiration Healthcare Group IHC £17m
Half-year Results Results
FY27 revenue expectation is raised to at least £43m, backed by 26% underlying H1 growth, a growing pipeline and a planned consumables launch. This is another step up after earlier upgrades.

Project milestones £43.0m · 259% of mcapahead of expectationsoutlook positive, raisedfirst in 8 months +5.4% on the day
Results reading The trading update's headline numbers are confirmed. What changed · 10 →
Moved: Sales momentum to continue into FY27; company expects to close FY27 slightly ahe: pending → on_track – Guidance is raised to at least £43m for FY27, with momentum expected to continue into FY28, consistent with finishing ahead of expectations. · Transfer infusion distribution to Micrel by January 2027 to focus on neonatal; n: pending → on_track – The Infusion Therapies transfer to Micrel remains set for 31 January 2027, and the staff moved on 1 July 2026. Net debt is £5.2m against £5.1m at the year end. · Grow consumables and service (recurring) revenue: pending → on_track – Underlying service revenue is up 21% and the first proprietary consumables launch is planned for Q4 FY27. Underlying consumables revenue was flat.